Provided by Tiger Fintech (Singapore) Pte. Ltd.

Bone Biologics Corp

2.86
-0.0600-2.05%
Post-market: 2.85-0.0100-0.35%19:44 EDT
Volume:85.95K
Turnover:249.22K
Market Cap:4.59M
PE:-0.14
High:2.97
Open:2.97
Low:2.84
Close:2.92
Loading ...
Oct 04, 2022

[Amend]Public Prospectus

S-1/A [Amend] - General form for registration of securities under the Securities Act of 1933
Sep 23, 2022

Public Prospectus

S-1 - General form for registration of securities under the Securities Act of 1933
Aug 24, 2022

Major Issues Report

8-K - Current report
Aug 11, 2022

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Jul 07, 2022

Correspondence

CORRESP [Cover] - Correspondence
Jun 09, 2022

Major Issues Report

8-K - Current report
May 23, 2022

Major Issues Report

8-K - Current report
May 13, 2022

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Mar 15, 2022

Annual Report

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Mar 08, 2022

Major Issues Report

8-K - Current report
Dec 22, 2021

Major Issues Report

8-K - Current report
Oct 21, 2021

Statement Of Changes In Beneficial Ownership

3 - Initial statement of beneficial ownership of securities
Oct 21, 2021

Statement Of Changes In Beneficial Ownership

3 - Initial statement of beneficial ownership of securities
Oct 19, 2021

Statement Of Changes In Beneficial Ownership

4 - Statement of changes in beneficial ownership of securities
Oct 08, 2021

Correspondence

CORRESP [Cover] - Correspondence
Oct 08, 2021

Correspondence

CORRESP [Cover] - Correspondence
Oct 07, 2021

[Amend]Public Prospectus

S-1/A [Amend] - General form for registration of securities under the Securities Act of 1933
Oct 06, 2021

[Amend]Public Prospectus

S-1/A [Amend] - General form for registration of securities under the Securities Act of 1933
Aug 30, 2021

[Amend]Public Prospectus

S-1/A [Amend] - General form for registration of securities under the Securities Act of 1933
Aug 16, 2021

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]